27.10.2022 23:02:13
|
Edwards Lifesciences Corp. Q3 Profit Increases, but misses estimates
(RTTNews) - Edwards Lifesciences Corp. (EW) reported a profit for its third quarter that increased from the same period last year but missed the Street estimates.
The company's bottom line came in at $343.5 million, or $0.55 per share. This compares with $340.1 million, or $0.54 per share, in last year's third quarter.
Excluding items, Edwards Lifesciences Corp. reported adjusted earnings of $383.8 million or $0.61 per share for the period.
Analysts on average had expected the company to earn $0.62 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.
The company's revenue for the quarter rose 0.8% to $1.32 billion from $1.31 billion last year.
Edwards Lifesciences Corp. earnings at a glance (GAAP) :
-Earnings (Q3): $343.5 Mln. vs. $340.1 Mln. last year. -EPS (Q3): $0.55 vs. $0.54 last year. -Analyst Estimate: $0.62 -Revenue (Q3): $1.32 Bln vs. $1.31 Bln last year.
-Guidance: Full year EPS guidance: $2.40 to $2.50
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Edwards Lifesciences Corp.mehr Nachrichten
Analysen zu Edwards Lifesciences Corp.mehr Analysen
Aktien in diesem Artikel
Edwards Lifesciences Corp. | 66,41 | -1,69% |